Alivio Therapeutics

Alivio Therapeutics

Alivio Therapeutics is pioneering a new way to treat inflammatory diseases based on precisely tuning the immune system.

Launch date
Boston Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound

$3.3m

Grant

N/A

Acquisition
Total Funding€3.0m

Recent News about Alivio Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.